Walletmor
Walletmor sells the world's first commercially available NFC payment implant — a subdermal biopolymer chip that enables contactless payments worldwide. The company sells directly to consumer early adopters via Shopify and distributes installation through 100+ vetted body modification and medical partners across Europe and the US.
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Walletmor does
Walletmor is a Polish-British startup founded in 2021 that sells the world's first commercially available, globally accepted subdermal NFC payment implant. The implant is a passive transponder — a silicon chip containing encrypted payment data and an NFC antenna, encapsulated in a USP Class VI certified biopolymer developed with VivoKey Technologies — that is implanted under the skin (typically in the hand) and enables contactless payments at any terminal accepting Visa/Mastercard contactless. The implant carries ISO 10993 biocompatibility certification and FDA-cleared materials, and communicates via the ISO 14443A protocol using EMV and 3-D Secure standards. The current-generation product has an 8-year validity period.
The company sells the implant directly to consumers through its Shopify e-commerce storefront at €299 (regular price €499), with free standard shipping and a €20 express option via DHL Express. There is no subscription, transaction fee, or licensing component — revenue is generated entirely from one-time hardware sales plus a small shipping fee. For EU/EEA/Swiss/UK customers, the implant is linked to an iCard digital wallet account; for US customers, it is linked to a Purewrist account. Distribution relies on a network of 100+ vetted installation partners across Europe, the US, and Scandinavia — including body modification artists, piercers, and medical clinics — which are listed on the Walletmor website. As of April 2021, the company reported approximately 200 active users across the UK, Germany, Poland, and Scandinavia, making it a niche, early-adopter business.
Walletmor is registered in London (Walletmor Ltd, Companies House no. 13048848) and operates across 30+ European countries plus the United States. The leadership team consists of CEO and founder Wojciech Paprota, CTO Amal Graafstra (also founder of VivoKey Technologies and Dangerous Things), and CLO Artur Bilski. Marketing is primarily organic and earned media, including a Money20/20 speaking slot and a Museum of the Future exhibition in Dubai. No institutional funding rounds are disclosed. The company has announced a planned adjacent product called Walletmed — a subdermal glucose-monitoring implant for diabetics — which would extend the implant technology into healthcare but has not yet been launched.
Walletmor firmographics
Firmographics- Name
- Walletmor
- Legal name
- Walletmor Ltd
- Website
- https://walletmor.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Walletmor sells the world's first commercially available NFC payment implant — a subdermal biopolymer chip that enables contactless payments worldwide. The company sells directly to consumer early adopters via Shopify and distributes installation through 100+ vetted body modification and medical partners across Europe and the US.
- Ownership category
- akta.pro rank
Walletmor industry classification
Industry- Product category
- Contactless Payment Hardware
- akta.pro primary industry
- Mobile Wallets (NFC Tap-to-Pay / HCE) (FSAMAEAB)
- akta.pro secondary industries
- Embedded Wallets (Platforms & Marketplaces) (FSAMAEAM), Payment PIN Pads, Card Readers & NFC Contactless Devices (HDACAKAG), Digital Wallet Platforms (Consumer & Merchant) (BPAMAFAC)
Keywords
Where Walletmor is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Walletmor business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel, Infrastructure
Revenue model
- Implant Hardware Sales: One-time sale of the Walletmor payment implant device. The implant is sold directly to consumers through the Shopify e-commerce platform. No subscription fees or maintenance charges apply. Revenue is generated entirely from the initial product purchase.
- Shipping Fees: Revenue generated from shipping charges for express delivery options. Standard shipping is free; express shipping via DHL Express costs €20.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Walletmor Payment Implant (8-year validity) - Current generation |
| One time/ perpetual license | Pay-as-you-go | Legacy Implant (2-year validity) - Discontinued generation |
| Unit Pricing | Pay-as-you-go | Standard Shipping |
| Unit Pricing | Pay-as-you-go | Express Shipping (DHL Express) |
| One time/ perpetual license | Pay-as-you-go | US Version Implant |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels8 records
Walletmor product offering
Product offeringCore offering
Walletmor designs, manufactures, and sells a subdermal NFC payment implant — a passive transponder consisting of a silicon chip and antenna encapsulated in FDA-confirmed, USP Class VI certified biopolymer. Once implanted (typically in the hand), the device enables contactless payments at any Visa/Mastercard contactless terminal worldwide by linking to an iCard (EU) or Purewrist (US) digital wallet account. The product is sold directly to consumers via e-commerce, with installation arranged separately through partner specialists.
Product overview
Walletmor offers a single core product - the Walletmor Payment Implant - which is a subdermal NFC-based payment device. The implant consists of an NFC chip (storing encrypted payment data), an NFC antenna (for terminal communication), and biopolymer encapsulation. For European customers, the implant links with iCard digital wallet; for US customers, it links with Purewrist. The company plans future expansion through Walletmed - a glucose monitoring implant for diabetics. Walletmor Ltd, registered in London, developed the world's first globally accepted payment implant launched in April 2021.
Differentiator
Problem solved
Functional benefit
Brands
- Walletmed: A pivot of Walletmor targeting the diabetics market using smart implant technology for glucose monitoring. Plans to create an implant that is irreplaceable, convenient, connected to smartphone, and potentially 10x cheaper than standard glucometers within 10 years.
Products and services
- Walletmor Payment Implant (EU Version) Subdermal NFC payment implant — a passive transponder with silicon chip and antenna in biocompatible biopolymer casing, designed for permanent implantation (typically in the hand). Enables contactless payments at any Visa/Mastercard contactless POS terminal worldwide by linking to an iCard EU digital wallet account. 8-year validity, sold at €299 (regular €499) with no subscription or per-transaction fees.
- Walletmor Payment Implant (US Version) US-specific version of the Walletmor subdermal NFC payment implant with identical technical specifications as the EU version, but links to Purewrist digital wallet app for US residents instead of iCard. Priced at €299.
Quantifiable outcome
- 72.1% of surveyed Poles worry about wallet/card theft, driving demand for theft-proof payment solutions like implants
- +4 more outcomes
Companies that use Walletmor
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Walletmor technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature4 records
Walletmor partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- VivoKey Technologies Inc.coreSeattle-based VivoKey Technologies developed the biocompatible biopolymer used in Walletmor implants. Amal Graafstra, VivoKey founder, serves as Walletmor's CTO. VivoKey is the world's largest producer of its kind implementing the digital identity ecosystem. Their laboratory created the safe biopolymer with USP Class VI certification.
- iCardcoreiCard is an independent Financial Institution registered in the European Union holding EMI (Electronic Money Institution) status. Walletmor implants are linked to iCard personal accounts for fund storage. iCard follows strict EU regulations for risk management and security. Customers set up iCard accounts to store disposable funds that are accessed via the implant for contactless payments.
- PurewristcorePurewrist is an independent digital wallet provider for US customers. US version of Walletmor implant links to Purewrist app instead of iCard. Users register at Purewrist, verify identity, and top up accounts for implant-based payments.
- KSEC Cyborg Center (UK)coreUK-based installation partner with multiple locations including Ipswich, Brackley, and Norwich. Professional body modification specialists offering Walletmor implant installation services.
- Dr. Szymon Manasterski / Centrum Medyczne MichalakcoreOrthopedic specialist at Michalak Medical Center in Wrocław, Poland. Recommended Walletmor installation partner specializing in musculoskeletal orthopedics and traumatology. Performs quick 4-minute implantation procedures under local anesthesia.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Walletmor competitors and assessment
Company assessmentMarket position
Weaknesses1 record
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Walletmor social profiles
Digital presenceWalletmor compliance and trust
Trust signalCompliance4 records
Walletmor financial estimates
Financial estimateRevenue estimate
Valuation estimate
Walletmor leadership team
Management profileNumber of profiles
Profiles3 records
Walletmor funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Walletmor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Walletmor
What does Walletmor do?
Walletmor designs, manufactures, and sells a subdermal NFC payment implant — a passive transponder consisting of a silicon chip and antenna encapsulated in FDA-confirmed, USP Class VI certified biopolymer. Once implanted (typically in the hand), the device enables contactless payments at any Visa/Mastercard contactless terminal worldwide by linking to an iCard (EU) or Purewrist (US) digital wallet account. The product is sold directly to consumers via e-commerce, with installation arranged separately through partner specialists.
Is Walletmor a public or private company?
Walletmor is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Walletmor founded?
Walletmor was founded in 2021. It employs 1 to 10 people.
Where is Walletmor based?
Walletmor is headquartered in London, United Kingdom, in the Europe region.
How does Walletmor make money?
Two revenue lines are on record. Implant Hardware Sales are the primary driver. The others are shipping Fees.
Does Walletmor have an API?
No public API is recorded for Walletmor.
What industry is Walletmor in?
Walletmor's product category is Contactless Payment Hardware. Its primary akta.pro industry code is FSAMAEAB, Mobile Wallets (NFC Tap-to-Pay / HCE), with a secondary code of FSAMAEAM, Embedded Wallets (Platforms & Marketplaces).